RESUMEN
Virus-like particles (VLPs) are multifunctional nanocarriers that mimic the architecture of viruses. They can serve as a safe platform for specific functionalization and immunization, which provides benefits in a wide range of biomedical applications. In this work, a new generation immunophotothermal agent is developed that adjuvants photothermal ablation using a chemically modified VLP called bacteriophage Qß. The design is based on the conjugation of near-infrared absorbing croconium dyes to lysine residues located on the surface of Qß, which turns it to a powerful NIR-absorber called PhotothermalPhage. This system can generate more heat upon 808 nm NIR laser radiation than free dye and possesses a photothermal efficiency comparable to gold nanostructures, yet it is biodegradable and acts as an immunoadjuvant combined with the heat it produces. The synergistic combination of thermal ablation with the mild immunogenicity of the VLP leads to effective suppression of primary tumors, reduced lung metastasis, and increased survival time.
Asunto(s)
OroRESUMEN
The emergence of drug delivery using water stable metal-organic frameworks has elicited a lot of interest in their biocompatibility. However, few studies have been conducted on their stability in common buffers, cell media, and blood proteins. For these studies, single crystal ZIF-8 approximately 1 um in diameter were synthesized, incubated with common laboratory buffers, cell media, and serum, and then characterized by PXRD, IR, DLS, and SEM. Time-resolved SEM and PXRD demonstrate that buffers containing phosphate and bicarbonate alter the appearance and composition of ZIF-8; however, cargo inside the ZIF-8 does not appear to leak out, in most of these buffers, even when the ZIF-8 itself is displaced by phosphates. On the other hand, blood proteins in serum dissolve ZIF-8, causing trapped biomolecules to escape. The study presented here suggests that ZIF-8 can undergo dramatic surface chemistry changes that may affect the interpretation of cellular uptake and cargo release data. On the other hand, it provides a rational explanation as to how ZIF-8 neatly dissolves in vivo.
RESUMEN
Drug delivery is commonly thought of as the performance of a drug in vivo. Rather, the process of drug delivery can comprise of the journey of the drug from manufacturer to clinic, clinic to patient, and patient to disease. Each step of the journey includes hurdles that must be overcome for the therapeutic to be successful. Recent developments in proteinaceous therapeutics have made the successful completion of this journey even more important because of the relatively fragile nature of proteins in a drug delivery context. Polymers have been demonstrated to be an effective complement to proteinaceous therapeutics throughout this journey owing to their flexibility in design and function. During transit from manufacturer to clinic, the proteinaceous drug is threatened by denaturation at elevated temperatures. Polymers can help improve the thermal stability of the drug at ambient shipping conditions, thereby reducing the need for an expensive cold chain to preserve its bioactivity. Upon arrival at the clinic, the drug must be reconstituted into a suitable formulation that can be introduced into the patient. Unfortunately, traditional drug formulations relying on oral administration are generally not suitable for proteinaceous drugs owing to the hostile environment of the stomach. Other traditional methods of drug administration-like hypodermic injections-frequently suffer from low patient compliance. Polymers have been explored to design drug formulations suitable for alternative methods of administration. Upon entry into the body, proteinaceous drugs are at risk for identification, destruction, and excretion by the immune system. Polymers can help drugs reprogram immune system response and, in some cases, elicit a synergistic immune response. The next phase of research on protein-polymer-based therapeutics encourages a holistic effort to design systems that can survive each stage of the drug delivery journey.
Asunto(s)
Sistemas de Liberación de Medicamentos , Polímeros/química , Proteínas/química , Humanos , Evasión Inmune , Polímeros/administración & dosificación , Proteínas/administración & dosificaciónRESUMEN
Controlling the uptake of nanomaterials into phagocytes is a challenging problem. We describe an approach to inhibit the cellular uptake by macrophages and HeLa cells of nanoparticles derived from bacteriophage Qß by conjugating negatively charged terminal hexanoic acid moieties onto its surface. Additionally, we show hydrazone linkers can be installed between the surface of Qß and the terminal hexanoic acid moieties, resulting in a pH-responsive conjugate that, in acidic conditions, can release the terminal hexanoic acid moiety and allow for the uptake of the Qß nanoparticle. The installation of the "pH switch" did not change the structure-function properties of the hexanoic acid moiety and the uptake of the Qß conjugates by macrophages.
Asunto(s)
Allolevivirus/química , Nanoconjugados/química , Fagocitos/metabolismo , Animales , Caproatos/química , Células HeLa , Humanos , Hidrazonas/química , Concentración de Iones de Hidrógeno , Ratones , Estructura Molecular , Células RAW 264.7 , Electricidad Estática , Relación Estructura-ActividadRESUMEN
Intracellular targeting is essential for the efficient delivery of drugs and nanotherapeutics. Transporting nanomaterials into cells' cytoplasm for therapeutic purposes can be challenging due to the endosomal trap and lysosomal degradation of cargo. To overcome this issue, we utilized chemical synthesis to design a functional carrier that can escape the endosome and deliver biological materials into the cytoplasm. We synthesized a thiol-sensitive maleimide linker that connects the well-known mitochondria targeting lipophilic triphenylphosphonium cation (TPP) to the surface of a proteinaceous nanoparticle based on the engineered virus-like particle (VLP) Qß. TPP facilitates endosomal escape by its lipophilic and cationic nature, which disrupts the endosomal membrane. Once in the cytosol, glutathione reacts with the thiol-sensitive maleimide linkers, severs the TPP from the nanoparticle, halting its trafficking to the mitochondria, and marooning it in the cytosol. We successfully demonstrated cytosolic delivery of a VLP loaded with Green Fluorescent Protein (GFP) in vitro and small-ultrared fluorescent protein (smURFP) in vivo, where evenly distributed fluorescence is observed in A549 human lung adenocarcinoma cells and the epithelial cells of BALB/c mice lungs. As a proof of concept, we encapsulated luciferase-targeted siRNA (siLuc) inside the VLP decorated with the maleimide-TPP (M-TPP) linker. We observed enhanced luminescence silencing in luciferase-expressing HeLa cells using our sheddable TPP linker compared to control VLPs.
Asunto(s)
Endosomas , Compuestos de Sulfhidrilo , Ratones , Animales , Humanos , Células HeLa , Endosomas/metabolismo , Luciferasas/metabolismo , Maleimidas , Compuestos de Sulfhidrilo/metabolismoRESUMEN
Virus-like particles are an emerging class of nano-biotechnology with the Tobacco Mosaic Virus (TMV) having found a wide range of applications in imaging, drug delivery, and vaccine development. TMV is typically produced in planta, and, as an RNA virus, is highly susceptible to natural mutation that may impact its properties. Over the course of 2 years, from 2018 until 2020, our laboratory followed a spontaneous point mutation in the TMV coat protein-first observed as a 30 Da difference in electrospray ionization mass spectrometry (ESI-MS). The mutation would have been difficult to notice by electrophoretic mobility in agarose or SDS-PAGE and does not alter viral morphology as assessed by transmission electron microscopy. The mutation responsible for the 30 Da difference between the wild-type (wTMV) and mutant (mTMV) coat proteins was identified by a bottom-up proteomic approach as a change from glycine to serine at position 155 based on collision-induced dissociation data. Since residue 155 is located on the outer surface of the TMV rod, it is feasible that the mutation alters TMV surface chemistry. However, enzyme-linked immunosorbent assays found no difference in binding between mTMV and wTMV. Functionalization of a nearby residue, tyrosine 139, with diazonium salt, also appears unaffected. Overall, this study highlights the necessity of standard workflows to quality-control viral stocks. We suggest that ESI-MS is a straightforward and low-cost way to identify emerging mutants in coat proteins.
Asunto(s)
Mutación/genética , Virus del Mosaico del Tabaco/genética , Cápside/metabolismo , Laboratorios , Mutagénesis/genética , Proteómica/métodos , ARN Viral/genética , Replicación Viral/genéticaRESUMEN
The emergence of viral nanotechnology over the preceding two decades has created a number of intellectually captivating possible translational applications; however, the in vitro fate of the viral nanoparticles in cells remains an open question. Herein, we investigate the stability and lifetime of virus-like particle (VLP) Qß-a representative and popular VLP for several applications-following cellular uptake. By exploiting the available functional handles on the viral surface, we have orthogonally installed the known FRET pair, FITC and Rhodamine B, to gain insight of the particle's behavior in vitro. Based on these data, we believe VLPs undergo aggregation in addition to the anticipated proteolysis within a few hours of cellular uptake.
Asunto(s)
Transferencia Resonante de Energía de Fluorescencia , Nanopartículas/química , Virus/metabolismo , Animales , Química Clic , Cobre/química , Humanos , Concentración de Iones de Hidrógeno , Células MCF-7 , Maleimidas/química , Ratones , Microscopía Confocal , Nanopartículas/metabolismo , Nanopartículas/toxicidad , Proteolisis , Células RAW 264.7 , Rodaminas/química , Rodaminas/metabolismo , Virus/efectos de los fármacosRESUMEN
Many contrast agents for magnetic resonance imaging are based on gadolinium, however side effects limit their use in some patients. Organic radical contrast agents (ORCAs) are potential alternatives, but are reduced rapidly in physiological conditions and have low relaxivities as single molecule contrast agents. Herein, we use a supramolecular strategy where cucurbit[8]uril binds with nanomolar affinities to ORCAs and protects them against biological reductants to create a stable radical in vivo. We further overcame the weak contrast by conjugating this complex on the surface of a self-assembled biomacromolecule derived from the tobacco mosaic virus.
RESUMEN
OBJECTIVE: ß-secretase/ß-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) is a key enzyme involved in Alzheimer's disease that has recently been implicated in insulin-independent glucose uptake in myotubes. However, it is presently unknown whether BACE1 and the product of its activity, soluble APPß (sAPPß), contribute to lipid-induced inflammation and insulin resistance in skeletal muscle cells. MATERIALS/METHODS: Studies were conducted in mouse C2C12 myotubes, skeletal muscle from Bace1-/-mice and mice treated with sAPPß and adipose tissue and plasma from obese and type 2 diabetic patients. RESULTS: We show that BACE1 inhibition or knockdown attenuates palmitate-induced endoplasmic reticulum (ER) stress, inflammation, and insulin resistance and prevents the reduction in Peroxisome Proliferator-Activated Receptor γ Co-activator 1α (PGC-1α) and fatty acid oxidation caused by palmitate in myotubes. The effects of palmitate on ER stress, inflammation, insulin resistance, PGC-1α down-regulation, and fatty acid oxidation were mimicked by soluble APPß in vitro. BACE1 expression was increased in subcutaneous adipose tissue of obese and type 2 diabetic patients and this was accompanied by a decrease in PGC-1α mRNA levels and by an increase in sAPPß plasma levels of obese type 2 diabetic patients compared to obese non-diabetic subjects. Acute sAPPß administration to mice reduced PGC-1α levels and increased inflammation in skeletal muscle and decreased insulin sensitivity. CONCLUSIONS: Collectively, these findings indicate that the BACE1 product sAPPß is a key determinant in ER stress, inflammation and insulin resistance in skeletal muscle and gluconeogenesis in liver.
Asunto(s)
Secretasas de la Proteína Precursora del Amiloide/metabolismo , Ácido Aspártico Endopeptidasas/metabolismo , Estrés del Retículo Endoplásmico/fisiología , Inflamación/metabolismo , Insulina/metabolismo , Músculo Esquelético/metabolismo , Transducción de Señal/fisiología , Animales , Línea Celular , Células Cultivadas , Estrés del Retículo Endoplásmico/efectos de los fármacos , Humanos , Resistencia a la Insulina/fisiología , Masculino , Ratones , Fibras Musculares Esqueléticas/efectos de los fármacos , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/efectos de los fármacos , FN-kappa B/metabolismo , Ácido Palmítico/farmacología , Transducción de Señal/efectos de los fármacosRESUMEN
INTRODUCTION: A nonlinear dynamic systems model has previously been proposed to explain pacing strategies employed during exercise. PURPOSE: This study was conducted to examine the pacing strategies used under varying conditions during the cycle phase of an Ironman triathlon. METHODS: The bicycles of six well-trained male triathletes were equipped with SRM power meters set to record power output, cadence, speed, and heart rate. The flat, three-lap, out-and-back cycle course, coupled with relatively consistent wind conditions (17-30 km x h(-1)), enabled comparisons to be made between three consecutive 60-km laps and relative wind direction (headwind vs tailwind). RESULTS: Participants finished the cycle phase (180 km) with consistently fast performance times (5 h, 11 +/- 2 min; top 10% of all finishers). Average power output (239 +/- 25 to 203 +/- 20 W), cadence (89 +/- 6 to 82 +/- 8 rpm), and speed (36.5 +/- 0.8 to 33.1 +/- 0.8 km x h(-1)) all significantly decreased with increasing number of laps (P < 0.05). These variables, however, were not significantly different between headwind and tailwind sections. The deviation (SD) in power output and cadence did not change with increasing number of laps; however, the deviations in torque (6.8 +/- 1.6 and 5.8 +/- 1.3 N x m) and speed (2.1 +/- 0.5 and 1.6 +/- 0.3 km x h(-1)) were significantly greater under headwind compared with tailwind conditions, respectively. The median power frequency tended to be lower in headwind (0.0480 +/- 0.0083) compared with tailwind (0.0531 +/- 0.0101) sections. CONCLUSION: These data show evidence that a nonlinear dynamic pacing strategy is used by well-trained triathletes throughout various segments and conditions of the Ironman cycle phase. Moreover, an increased variation in torque and speed was found in the headwind versus the tailwind condition.
Asunto(s)
Ciclismo/fisiología , Resistencia Física/fisiología , Análisis y Desempeño de Tareas , Adulto , Análisis de Varianza , Análisis de Fourier , Frecuencia Cardíaca/fisiología , Humanos , MasculinoRESUMEN
PURPOSE: : Although manufacturers of bicycle power monitoring devices SRM and Power Tap (PT) claim accuracy to within 2.5%, there are limited scientific data available in support. The purpose of this investigation was to assess the accuracy of SRM and PT under different conditions. METHODS: : First, 19 SRM were calibrated, raced for 11 months, and retested using a dynamic CALRIG (50-1000 W at 100 rpm). Second, using the same procedure, five PT were repeat tested on alternate days. Third, the most accurate SRM and PT were tested for the influence of cadence (60, 80, 100, 120 rpm), temperature (8 and 21 degrees C) and time (1 h at ~300 W) on accuracy. Finally, the same SRM and PT were downloaded and compared after random cadence and gear surges using the CALRIG and on a training ride. RESULTS: : The mean error scores for SRM and PT factory calibration over a range of 50 - 1000 W were 2.3 +/- 4.9% and -2.5 +/- 0.5%, respectively. A second set of trials provided stable results for 15 calibrated SRM after 11 months (-0.8 +/- 1.7%), and follow-up testing of all PT units confirmed these findings (-2.7 +/- 0.1%). Accuracy for SRM and PT was not largely influenced by time and cadence; however, power output readings were noticeably influenced by temperature (5.2% for SRM and 8.4% for PT). During field trials, SRM average and max power were 4.8% and 7.3% lower, respectively, compared with PT. CONCLUSIONS: : When operated according to manufacturers instructions, both SRM and PT offer the coach, athlete, and sport scientist the ability to accurately monitor power output in the lab and the field. Calibration procedures matching performance tests (duration, power, cadence, and temperature) are, however, advised as the error associated with each unit may vary.
Asunto(s)
Ciclismo , Monitoreo Fisiológico/instrumentación , Australia , CalibraciónRESUMEN
There is substantial evidence that static stretching may inhibit performance in strength and power activities. However, most of this research has involved stretching routines dissimilar to those practiced by athletes. The purpose of this study was to evaluate whether the decline in performance normally associated with static stretching pervades when the static stretching is conducted prior to a sport specific warm-up. Thirteen netball players completed two experimental warm-up conditions. Day 1 warm-up involved a submaximal run followed by 15 min of static stretching and a netball specific skill warm-up. Day 2 followed the same design; however, the static stretching was replaced with a 15 min dynamic warm-up routine to allow for a direct comparison between the static stretching and dynamic warm-up effects. Participants performed a countermovement vertical jump and 20m sprint after the first warm-up intervention (static or dynamic) and also after the netball specific skill warm-up. The static stretching condition resulted in significantly worse performance than the dynamic warm-up in vertical jump height (-4.2%, 0.40 ES) and 20m sprint time (1.4%, 0.34 ES) (p<0.05). However, no significant differences in either performance variable were evident when the skill-based warm-up was preceded by static stretching or a dynamic warm-up routine. This suggests that the practice of a subsequent high-intensity skill based warm-up restored the differences between the two warm-up interventions. Hence, if static stretching is to be included in the warm-up period, it is recommended that a period of high-intensity sport-specific skills based activity is included prior to the on-court/field performance.
Asunto(s)
Rendimiento Atlético/fisiología , Ejercicios de Estiramiento Muscular/métodos , Deportes/fisiología , Adolescente , Ejercicio Físico/fisiología , Humanos , Ejercicios de Estiramiento Muscular/efectos adversos , Adulto JovenRESUMEN
We investigated the effects of an Ironman triathlon race on markers of muscle damage, inflammation and heat shock protein 70 (HSP70). Nine well-trained male triathletes (mean +/- SD age 34 +/- 5 years; VO(2peak) 66.4 ml kg(-1) min(-1)) participated in the 2004 Western Australia Ironman triathlon race (3.8 km swim, 180 km cycle, 42.2 km run). We assessed jump height, muscle strength and soreness, and collected venous blood samples 2 days before the race, within 30 min and 14-20 h after the race. Plasma samples were analysed for muscle proteins, acute phase proteins, cytokines, heat shock protein 70 (HSP70), and clinical biochemical variables related to dehydration, haemolysis, liver and renal functions. Muscular strength and jump height decreased significantly (P < 0.05) after the race, whereas muscle soreness and the plasma concentrations of muscle proteins increased. The cytokines interleukin (IL)-1 receptor antagonist, IL-6 and IL-10, and HSP70 increased markedly after the race, while IL-12p40 and granulocyte colony-stimulating factor (G-CSF) were also elevated. IL-4, IL-1beta and tumour necrosis factor-alpha did not change significantly, despite elevated C-reactive protein and serum amyloid protein A on the day after the race. Plasma creatinine, uric acid and total bilirubin concentrations and gamma-glutamyl transferase activity also changed after the race. In conclusion, despite evidence of muscle damage and an acute phase response after the race, the pro-inflammatory cytokine response was minimal and anti-inflammatory cytokines were induced. HSP70 is released into the circulation as a function of exercise duration.
Asunto(s)
Ciclismo/fisiología , Músculo Esquelético/lesiones , Resistencia Física/fisiología , Carrera/fisiología , Natación/fisiología , Reacción de Fase Aguda/metabolismo , Adulto , Citocinas/sangre , Deshidratación/sangre , Proteínas HSP70 de Choque Térmico/sangre , Hemólisis , Humanos , Mediadores de Inflamación/sangre , Masculino , Músculo Esquelético/metabolismoRESUMEN
The aims of this study were to compare the physiological and anthropometric characteristics of successful mountain bikers and professional road cyclists and to re-examine the power-to-weight characteristics of internationally competitive mountain bikers. Internationally competitive cyclists (seven mountain bikers and seven road cyclists) completed the following tests: anthropometric measurements, an incremental cycle ergometer test and a 30 min laboratory time-trial. The mountain bikers were lighter (65.3+/-6.5 vs 74.7+/-3.8 kg, P= 0.01; mean +/- s) and leaner than the road cyclists (sum of seven skinfolds: 33.9+/-5.7 vs 44.5+/-10.8 mm, P = 0.04). The mountain bikers produced higher power outputs relative to body mass at maximal exercise (6.3+/-0.5 vs 5.8+/-0.3 W x kg(-1), P= 0.03), at the lactate threshold (5.2+/-0.6 vs 4.7+/-0.3 W x kg(-1), P= 0.048) and during the 30 min time-trial (5.5+/-0.5 vs 4.9+/-0.3 W x kg(-1), P = 0.02). Similarly, peak oxygen uptake relative tobody mass was higher in the mountain bikers (78.3+/-4.4 vs 73.0+/-3.4 ml x kg(-1) x min(-1), P = 0.03). The results indicate that high power-to-weight characteristics are important for success in mountain biking. The mountain bikers possessed similar anthropometric and physiological characteristics to previously studied road cycling uphill specialists.